In an energy starved, water-scarce India, these challenges are even more accentuated. According to the World Bank, India has ...

Vir Biotechnology, Inc. today announced that Week 48 endpoint analysis from the Company's Phase 2 SOLSTICE trial for chronic hepatitis delta (CHD) demonstrated that participants receiving a monthly ...